Biphenyl amide p38 kinase inhibitors 2: Optimisation and SAR
摘要:
The biphenyl amides are a novel series of p38 MAP kinase inhibitors. Structure-activity relationships of the series against p38 alpha are discussed with reference to the X-ray crystal structure of an example. The series was optimised rapidly to a compound showing oral activity in an in vivo disease model. (C) 2007 Elsevier Ltd. All rights reserved.
Biphenyl amide p38 kinase inhibitors 2: Optimisation and SAR
摘要:
The biphenyl amides are a novel series of p38 MAP kinase inhibitors. Structure-activity relationships of the series against p38 alpha are discussed with reference to the X-ray crystal structure of an example. The series was optimised rapidly to a compound showing oral activity in an in vivo disease model. (C) 2007 Elsevier Ltd. All rights reserved.
5-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
申请人:——
公开号:US20040242868A1
公开(公告)日:2004-12-02
Compounds of formula (I):
1
or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
Compounds of formula (I), or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
1
Biphenylcarboxylic amide derivatives as p38-kinase inhibitors
申请人:Angell Martyn Richard
公开号:US20050020540A1
公开(公告)日:2005-01-27
Compounds of formula (I): or pharmaceutically acceptable sats or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
化合物公式(I)的药物可接受盐或溶剂化物,以及它们作为药物的用途,特别是作为p38激酶抑制剂。
Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors
申请人:Angell Martyn Richard
公开号:US20070105860A1
公开(公告)日:2007-05-10
Compounds of formula (I):
or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
Compounds of formula (I):
or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.